-
Human T-Cell Leukemia Virus (HTLV) Treatments: A Focus on Cepharanthine
David Orchard-Webb
August 01, 2024
Human T-cell leukemia virus is a retrovirus that infects T-cells. One promising therapeutic agent is Cepharanthine, a natural alkaloid with antiviral properties.
-
Current Status of Research and Application of Preventive Human Papillomavirus (HPV) Vaccines
Xiaomichong
July 23, 2025
In recent years, the topic of "HPV vaccine" has maintained a high level of attention, with netizens complaining about the difficulty of obtaining a vaccine.
-
Research Progress on Therapeutic Human Papillomavirus (HPV) Vaccines
Xiaomichong
July 23, 2025
Currently, the research and development technology for prophylactic human papillomavirus (HPV) vaccines is becoming increasingly mature (related reading: "Current Status of Research and Application of Prophylactic Human Papillomavirus (HPV) Vaccines").
-
What are the Human Errors in Pharma Industry and How to Prevent them?
Muhammad Asim Niazi
July 13, 2023
Process and manufacturing industries worldwide are prone to human errors, the most common error type faced by these industries.
-
Human trial data of oral small molecule PD-1/PD-L1 inhibitors were first released
PharmaSources/Xiaoyaowan
December 02, 2021
Recently, Incyte of the United States reported the Phase I clinical data of oral small molecule PD-L1 inhibitor INCB086550 in Journal for ImmunoTherapy of Cancer.
-
The Impact of the Human Genome Project on China Pharmaceutical Industry 20 Years Later
Lin Zhang
December 24, 2020
The Human Genome Project (HGP) is the first and greatest endeavor so far to understand ourselves and all other types of life through the vast international collaboration.
-
Immuno Cure and PharmaJet Announce Collaboration to Advance a Novel HIV Therapeutic DNA Vaccine Using Needle-Free Technology in Humans
PRNewswire
June 19, 2025
Immuno Cure and PharmaJet have announced a collaboration to clinically evaluate ICVAX, an innovative HIV therapeutic DNA vaccine, using PharmaJet's needle-free delivery technology.
-
Microtech Announces First Human Case of Implantable Microsensor for Heart Failure
PRNewswire
December 27, 2024
Microtech announced that it has initiated human clinical trials of their microsensor platform, in a trial to measure atrial pressures important for the treatment of heart failure.
-
CBC Group R-Bridge Healthcare Fund Announces up to US$50 Million Financing for Human Investments Ltd. to Fund Motiva? Market Expansion
PR Newswire
December 12, 2024
R-Bridge Healthcare Fund ("R-Bridge") today announced the closing of a non-dilutive growth financing facility of up to US$50 million for Human Investments Ltd.
-
Adoption of an Exclusive Human Milk Diet Reduces Malnutrition Rates Among Vulnerable Premature Infants in Sydney Hospital
PRNewswire
December 10, 2024
Prolacta Bioscience?, the world's leading hospital provider of 100% human milk-based nutritional products, today announced results of an interim subgroup analysis of a prospective observational study.